M Holdings Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $521K | Sell |
10,261
-451
| -4% | -$24.4K | 0.04% | 249 |
|
|
2025
Q4 | $525K | Buy |
+10,712
| New | +$500K | 0.04% | 244 |
|
|
2024
Q3 | – | Sell |
-13,881
| Closed | -$534K | – | 189 |
|
|
2024
Q2 | $534K | Buy |
+13,881
| New | +$584K | 0.07% | 153 |
|
|
2023
Q2 | – | Sell |
-8,196
| Closed | -$292K | – | 308 |
|
|
2023
Q1 | $292K | Sell |
8,196
-125
| -2% | -$4.37K | 0.03% | 357 |
|
|
2022
Q4 | $292K | Sell |
8,321
-741
| -8% | -$24.7K | 0.03% | 346 |
|
|
2022
Q3 | $267K | Buy |
9,062
+1,397
| +18% | +$52.9K | 0.03% | 345 |
|
|
2022
Q2 | $417K | Sell |
7,665
-1,445
| -16% | -$79.8K | 0.04% | 278 |
|
|
2022
Q1 | $496K | Buy |
+9,110
| New | +$495K | 0.04% | 299 |
|
|
2021
Q2 | $453K | Sell |
9,108
-1,069
| -11% | -$51.4K | 0.04% | 190 |
|
|
2021
Q1 | $454K | Buy |
10,177
+978
| +11% | +$44.4K | 0.04% | 310 |
|
|
2020
Q4 | $423K | Buy |
+9,199
| New | +$423K | 0.05% | 164 |
|
|
2019
Q2 | – | Sell |
-7,646
| Closed | -$399K | – | 238 |
|
|
2019
Q1 | $399K | Buy |
7,646
+1,583
| +26% | +$79.1K | 0.09% | 232 |
|
|
2018
Q4 | $290K | Buy |
6,063
+821
| +16% | +$40.4K | 0.09% | 251 |
|
|
2018
Q3 | $263K | Sell |
5,242
-50
| -0.9% | -$2.54K | 0.07% | 288 |
|
|
2018
Q2 | $267K | Sell |
5,292
-574
| -10% | -$28.9K | 0.07% | 285 |
|
|
2018
Q1 | $286K | Sell |
5,866
-3,220
| -35% | -$150K | 0.09% | 256 |
|
|
2017
Q4 | $403K | Buy |
9,086
+2,852
| +46% | +$132K | 0.12% | 206 |
|
|
2017
Q3 | $316K | Sell |
6,234
-2,040
| -25% | -$103K | 0.1% | 235 |
|
|
2017
Q2 | $446K | Sell |
8,274
-2,642
| -24% | -$141K | 0.15% | 176 |
|
|
2017
Q1 | $575K | Sell |
10,916
-1,118
| -9% | -$56.7K | 0.22% | 127 |
|
|
2016
Q4 | $579K | Buy |
12,034
+1,412
| +13% | +$69.8K | 0.2% | 120 |
|
|
2016
Q3 | $573K | Sell |
10,622
-335
| -3% | -$18.4K | 0.26% | 113 |
|
|
2016
Q2 | $594K | Sell |
10,957
-172
| -2% | -$9.06K | 0.3% | 96 |
|
|
2016
Q1 | $564K | Buy |
11,129
+4,263
| +62% | +$212K | 0.35% | 88 |
|
|
2015
Q4 | $346K | Sell |
6,866
-358
| -5% | -$18.2K | 0.23% | 131 |
|
|
2015
Q3 | $347K | Buy |
7,224
+242
| +3% | +$12.6K | 0.25% | 121 |
|
|
2015
Q2 | $364K | Sell |
6,982
-215
| -3% | -$12.1K | 0.24% | 120 |
|
|
2015
Q1 | $415K | Buy |
7,197
+3
| +0% | +$172 | 0.27% | 111 |
|
|
2014
Q4 | $384K | Buy |
7,194
+1,281
| +22% | +$71.7K | 0.25% | 115 |
|
|
2014
Q3 | $349K | Buy |
5,913
+2,719
| +85% | +$167K | 0.19% | 122 |
|
|
2014
Q2 | $214K | Buy |
+3,194
| New | +$216K | 0.14% | 170 |
|
Other funds holding GSK
JEST
M Holdings Securities's GSK Position: Q1 2026 in Review
M Holdings Securities reduced its GSK (GSK) stake by 4.2% in Q1 2026, selling an estimated $24.4K and leaving 10,261 shares worth $521K. The position accounts for 0.04% of the portfolio, ranked #249.
M Holdings Securities first reported a position in GSK in Q2 2014 and has held it in 31 quarters since. The position peaked at $594K in Q2 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- M Holdings Securities held 10,261 shares of GSK worth $521K as of Q1 2026.
- M Holdings Securities sold 451 GSK shares in Q1 2026, an estimated $24.4K.
- GSK made up 0.04% of M Holdings Securities's portfolio in Q1 2026, its #249 holding.
- M Holdings Securities first reported a position in GSK in Q2 2014 and has held it in 31 quarters since.
- M Holdings Securities's GSK position peaked at $594K in Q2 2016.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on M Holdings Securities's 13F filing for Q1 2026, filed 12 May 2026.